Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 3 1Phase 1 1

Status

Completed 89Terminated 24Unknown 19Withdrawn 5Active not recruiting 5Recruiting 4Not yet recruiting 3Suspended 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 4

Conditions

Colorectal Neoplasms 33Pancreatic Neoplasms 14Neuroblastoma 12Neoplasm Metastasis 10Stomach Neoplasms 8Neoplasms 8Rectal Neoplasms 5Small Cell Lung Carcinoma 4Esophageal Squamous Cell Carcinoma 4Colonic Neoplasms 4Sarcoma, Ewing 3Rhabdomyosarcoma 3Ovarian Neoplasms 3Breast Neoplasms 3Adenocarcinoma 3Wilms Tumor 2Sarcoma 2Recurrence 2Osteosarcoma 2Gastrointestinal Neoplasms 2Ganglioneuroblastoma 2Esophageal Neoplasms 2Endometrial Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Biliary Tract Neoplasms 2Adenocarcinoma Of Esophagus 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Solid Tumors 1

Interventions

Oxaliplatin 13Bevacizumab 11Capecitabine 10Fluorouracil 8Blood Specimen Collection 8Leucovorin 7Cetuximab 7Folfox protocol 6pembrolizumab 5Drug Therapy 5trifluridine tipiracil drug combination 4dostarlimab 4Nivolumab 4Irinotecan 4HMPL-013 4fludarabine 3XELOX 3Specimen Handling 3IFL protocol 3Cyclophosphamide 3Biopsy 3toripalimab 2tislelizumab 2tipiracil 2regorafenib 2pertuzumab 2envafolimab 2encorafenib 2cemiplimab 2atezolizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Recruiting × Colonic Neoplasms × Irinotecan × Clear all
NCT04920032 2026-05-11

Study of ctDNA Guided Change in Tx for Refractory Minimal Residual Disease in Colon Adenocarcinomas

University of California, Irvine

Phase 1 Recruiting
22 enrolled
Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

NCT05806931 2026-03-18

SCOTI

Rutgers, The State University of New Jersey

Phase 2 Recruiting
50 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms

NCT07011576 2026-03-18

FRUITFUL

SCRI Development Innovations, LLC

Phase 2 Recruiting
60 enrolled
Gastrointestinal

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT06490536 2025-08-29

The Sagittarius Trial

IFOM ETS - The AIRC Institute of Molecular Oncology

Phase 3 Recruiting
700 enrolled
Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡